These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37401710)

  • 41. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.
    Rebillard X; Soulié M; Chartier-Kastler E; Davin JL; Mignard JP; Moreau JL; Coulange C;
    BJU Int; 2008 May; 101(10):1205-13. PubMed ID: 18325057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.
    Chaussy C; Thüroff S
    Curr Urol Rep; 2003 Jun; 4(3):248-52. PubMed ID: 12756090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High intensity focused ultrasound with Focal-One
    Perez-Reggeti JI; Sanchez-Salas R; Sivaraman A; Linares Espinos E; de Gracia-Nieto AE; Barret E; Galiano M; Rozet F; Fregeville A; Renard-Penna R; Cathala N; Mombet A; Prapotnich D; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):608-614. PubMed ID: 27543259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer.
    Dickinson L; Ahmed HU; Hindley RG; McCartan N; Freeman A; Allen C; Emberton M; Kirkham AP
    Urol Oncol; 2017 Jan; 35(1):30.e9-30.e15. PubMed ID: 27663393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experience.
    Collins K; Brocken E; Bahler CD; Alabd A; Koch MO; Cheng L
    Hum Pathol; 2022 Jan; 119():79-84. PubMed ID: 34801600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.
    Apfelbeck M; Chaloupka M; Schlenker B; Stief CG; Clevert DA
    Clin Hemorheol Microcirc; 2019; 73(1):135-143. PubMed ID: 31561350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The correlation of PSA-nadir PS recurrence after total HIFU-ablation in patients with localized prostate cancer].
    Fomkin RN; Krupinov GE; Churakov AA; Shatylko TV; Fomkina OA; Zhmakin VA
    Urologiia; 2020 Sep; (4):79-83. PubMed ID: 32897659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer.
    Hatiboglu G; Popeneciu IV; Deppert M; Nyarangi-Dix J; Hadaschik B; Hohenfellner M; Teber D; Pahernik S
    BMC Urol; 2017 Jan; 17(1):5. PubMed ID: 28077116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [High-intensity focussed ultrasound in low-risk prostate cancer - oncological outcome and postinterventional quality of life of an inexperienced therapy centre in comparison with an experienced therapy centre].
    Baumunk D; Andersen C; Heile U; Ebbing J; Cash H; Porsch M; Liehr UB; Janitzky A; Wendler JJ; Schindele D; Blaschke S; Miller K; Schostak M
    Aktuelle Urol; 2013 Jul; 44(4):285-92. PubMed ID: 23888408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year].
    Arnouil N; Gelet A; Matillon X; Rouviere O; Colombel M; Ruffion A; Mège-Lechevallier F; Subtil F; Badet L; Crouzet S
    Prog Urol; 2018 Oct; 28(12):603-610. PubMed ID: 30243461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High intensity focused ultrasound (HIFU).
    Barkin J
    Can J Urol; 2011 Apr; 18(2):5634-43. PubMed ID: 21504653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
    Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom.
    Johnston MJ; Emara A; Noureldin M; Bott S; Hindley RG
    Urology; 2019 Nov; 133():175-181. PubMed ID: 31449831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysis.
    Capogrosso P; Barret E; Sanchez-Salas R; Nunes-Silva I; Rozet F; Galiano M; Ventimiglia E; Briganti A; Salonia A; Montorsi F; Cathelineau X
    Eur J Surg Oncol; 2018 Jan; 44(1):185-191. PubMed ID: 29223469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. External validation of biochemical recurrence definition to predict oncologic outcomes following focal therapy for localized prostate cancer using high intensity focused ultrasound.
    Mattlet A; Limani K; Alexandre P; Hawaux E; Abou Zahr R; Aoun F; Diamand R
    Prostate; 2023 Dec; 83(16):1564-1571. PubMed ID: 37574824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.